Revision history of "Development and implementation of an innovative combination of cardiovascular polytherapy with associated risk factors" (Q77766)

12 October 2024

• curprev 21:3421:34, 12 October 2024‎ DG Regio talk contribs‎ 93,011 bytes −34‎ ‎Changed label, description and/or aliases in pt
• curprev 21:3421:34, 12 October 2024‎ DG Regio talk contribs‎ 93,045 bytes −116‎ ‎Set a claim value: summary (P836): O projeto resultará numa combinação de rosuvastatina e telmistartan, que não tem contrapartida no mercado europeu. Este medicamento responde aos problemas dos doentes com o tratamento de doenças cardiovasculares e riscos cardiovasculares associados. A indicação terapêutica será o tratamento da hipertensão em doentes adultos com um risco estimado elevado de um primeiro acontecimento cardiovascular (profilaxia de acontecimentos graves deste tipo) ou n...

22 March 2024

• curprev 14:3314:33, 22 March 2024‎ DG Regio talk contribs‎ 93,161 bytes +288‎ ‎Added qualifier: readability score (P590521): 0.3779012508674212

12 January 2024

• curprev 16:0816:08, 12 January 2024‎ DG Regio talk contribs‎ 92,873 bytes +1,444‎ ‎Changed an Item

14 June 2023

• curprev 18:2518:25, 14 June 2023‎ Admin talk contribs‎ 91,429 bytes +415‎ BatchIngestion

11 June 2023

• curprev 11:0811:08, 11 June 2023‎ Admin talk contribs‎ 91,014 bytes +435‎ BatchIngestion

24 May 2023

• curprev 16:5816:58, 24 May 2023‎ DG Regio talk contribs‎ 90,579 bytes +949‎ ‎Changed an Item

2 March 2023

• curprev 22:2022:20, 2 March 2023‎ DG Regio talk contribs‎ 89,630 bytes +2,014‎ ‎Changed label, description and/or aliases in it, lv, da, sk, ro, cs, pt, de, sv, et, lt, sl, ga, bg, es, hu, fr, hr, mt, fi, el, nl, and other parts

25 October 2022

• curprev 09:4309:43, 25 October 2022‎ DG Regio talk contribs‎ 87,616 bytes +855‎ ‎Changed an Item: Import item from Poland

19 October 2022

• curprev 15:1515:15, 19 October 2022‎ DG Regio talk contribs‎ 86,761 bytes +1,230‎ ‎Changed an Item: Import item from Poland
• curprev 15:1515:15, 19 October 2022‎ DG Regio talk contribs‎ 85,531 bytes −419‎ ‎Removed claim: co-financing rate (P837): 49.28 percentage
• curprev 15:1515:15, 19 October 2022‎ DG Regio talk contribs‎ 85,950 bytes −411‎ ‎Removed claim: instance of (P35): Discontinued Kohesio Project (Q4412041)
• curprev 15:1515:15, 19 October 2022‎ DG Regio talk contribs‎ 86,361 bytes −5‎ ‎Changed an Item: Continued project

17 October 2022

• curprev 15:3915:39, 17 October 2022‎ DG Regio talk contribs‎ 86,366 bytes +416‎ ‎Changed an Item: Discontinued project

13 August 2022

• curprev 16:1516:15, 13 August 2022‎ DG Regio talk contribs‎ 85,950 bytes +55,078‎ ‎Changed label, description and/or aliases in et, lt, hr, el, sk, fi, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

19 January 2022

• curprev 11:1411:14, 19 January 2022‎ DG Regio talk contribs‎ 30,872 bytes +3,148‎ ‎Changed label, description and/or aliases in es, and other parts: Adding Spanish translations

15 January 2022

• curprev 22:1722:17, 15 January 2022‎ DG Regio talk contribs‎ 27,724 bytes +3,035‎ ‎Changed label, description and/or aliases in it, and other parts: Adding Italian translations

16 December 2021

• curprev 19:1719:17, 16 December 2021‎ DG Regio talk contribs‎ 24,689 bytes +3,195‎ ‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations

7 December 2021

• curprev 08:0108:01, 7 December 2021‎ DG Regio talk contribs‎ 21,494 bytes +3,139‎ ‎Changed label, description and/or aliases in de, and other parts: Adding German translations

30 November 2021

• curprev 14:1914:19, 30 November 2021‎ DG Regio talk contribs‎ 18,355 bytes +2,949‎ ‎Created claim: summary (P836): Le projet aboutira à une combinaison de rosuvastatine et de Telmistartan, qui n’a pas d’équivalent sur le marché européen. Ce médicament est la réponse d’Adamed aux problèmes des patients liés au traitement des affections cardiovasculaires et des risques cardiovasculaires associés. L’indication thérapeutique du médicament sera le traitement de l’hypertension chez les patients adultes présentant un risque élevé de premier événement cardiovasculai...
• curprev 14:1914:19, 30 November 2021‎ DG Regio talk contribs‎ 15,406 bytes +224‎ ‎Changed label, description and/or aliases in fr: translated_label

29 October 2020

• curprev 04:5404:54, 29 October 2020‎ DG Regio talk contribs‎ 15,182 bytes −406‎ ‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement
• curprev 04:5404:54, 29 October 2020‎ DG Regio talk contribs‎ 15,588 bytes −34‎ ‎Changed label, description and/or aliases in 2 languages: Changing unique label-description pair

14 October 2020

• curprev 10:1610:16, 14 October 2020‎ DG Regio talk contribs‎ 15,622 bytes +178‎ ‎Changed label, description and/or aliases in 1 language: translated_label
• curprev 10:1610:16, 14 October 2020‎ DG Regio talk contribs‎ 15,444 bytes −181‎ ‎Changed label, description and/or aliases in 1 language: remove_english_label
• curprev 10:1610:16, 14 October 2020‎ DG Regio talk contribs‎ 15,625 bytes +2,759‎ ‎Created claim: summary (P836): The project will result in a combination of rosuvastatin and telmistartan, which has no counterpart on the European market. This medicine responds to the problems of patients with the treatment of cardiovascular conditions and associated cardiovascular risks. The therapeutic indication will be the treatment of hypertension in adult patients with a high estimated risk of a first cardiovascular event (prophylaxis of serious events of this type) or...
• curprev 10:1610:16, 14 October 2020‎ DG Regio talk contribs‎ 12,866 bytes −1,951‎ ‎Removed claim: summary (P836): The result of the project will be a composite medicine, which has not had its counterpart on the European market.This medicine is a response to the problems of patients in terms of cardiovascular medical treatment of co-morbidities and cardiovascular risks.The therapeutic indication of the preparation will treat blood pressure from adult patients with a high estimated risk of a first cardiovascular event (prevention of serious incidents of thi...

25 September 2020

• curprev 00:0800:08, 25 September 2020‎ DG Regio talk contribs‎ 14,817 bytes +1,160‎ ‎Changed an Item: Fixing rounding issue
• curprev 00:0800:08, 25 September 2020‎ DG Regio talk contribs‎ 13,657 bytes −1,162‎ ‎Removed claim: budget (P474): 1,539,457.4784 euro

23 September 2020

• curprev 04:4304:43, 23 September 2020‎ DG Regio talk contribs‎ 14,819 bytes +1,159‎ ‎Changed an Item: Fixing rounding issue
• curprev 04:4304:43, 23 September 2020‎ DG Regio talk contribs‎ 13,660 bytes −1,161‎ ‎Removed claim: EU contribution (P835): 758,592.1464 euro

15 July 2020

• curprev 18:1118:11, 15 July 2020‎ DG Regio talk contribs‎ 14,821 bytes +431‎ ‎Changed an Item

9 June 2020

• curprev 15:1915:19, 9 June 2020‎ DG Regio talk contribs‎ 14,390 bytes +429‎ ‎Changed an Item

6 June 2020

• curprev 20:1520:15, 6 June 2020‎ DG Regio talk contribs‎ 13,961 bytes +431‎ ‎Changed an Item

26 March 2020

• curprev 10:1210:12, 26 March 2020‎ DG Regio talk contribs‎ 13,530 bytes +431‎ ‎Changed an Item

4 March 2020

• curprev 08:5408:54, 4 March 2020‎ DG Regio talk contribs‎ 13,099 bytes +1,951‎ ‎Created claim: summary (P836): The result of the project will be a composite medicine, which has not had its counterpart on the European market.This medicine is a response to the problems of patients in terms of cardiovascular medical treatment of co-morbidities and cardiovascular risks.The therapeutic indication of the preparation will treat blood pressure from adult patients with a high estimated risk of a first cardiovascular event (prevention of serious incidents of this...

18 February 2020

• curprev 07:0407:04, 18 February 2020‎ DG Regio talk contribs‎ 11,148 bytes +181‎ ‎Changed an Item: Label in wikidata changed

8 February 2020

• curprev 15:4915:49, 8 February 2020‎ DG Regio talk contribs‎ 10,967 bytes +823‎ ‎Changed an Item
• curprev 15:4915:49, 8 February 2020‎ DG Regio talk contribs‎ 10,144 bytes −417‎ ‎Removed claim: financed by (P890): European Union (Q1)

31 January 2020

• curprev 15:4015:40, 31 January 2020‎ DG Regio talk contribs‎ 10,561 bytes +1,347‎ ‎Changed an Item
• curprev 15:4015:40, 31 January 2020‎ DG Regio talk contribs‎ 9,214 bytes −844‎ ‎Removed claims
• curprev 09:4509:45, 31 January 2020‎ DG Regio talk contribs‎ 10,058 bytes +844‎ ‎Changed an Item

13 January 2020

• curprev 20:5420:54, 13 January 2020‎ DG Regio talk contribs‎ 9,214 bytes +9,214‎ ‎Created a new Item